KMT2A and chronic myelogenous leukemia, BCR-ABL1 positive: miR-17-92 is also overexpressed in MLL (mixed lineage leukemia)-rearranged acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) [25], and in CD34+ chronic myeloid leukemia (CML) [26].